Given that cancer cells, even under non-hypoxic conditions, are capable of inducing HIF-1α and can actively shift their energy production from mitochondrial to glycolytic sources 44, our data suggest that treatment of oxLDL mimics a 'Warburg'-like effect in KLM-1 pancreatic cancer cells. The gene discussed is HIF1A; the disease is cancer.